Device / Technology News

RSS

Jersey Shore completes first procedure with Abiomed's Impella 2.5 heart pump

Jersey Shore University Medical Center announces the completion of its first procedure with Abiomed's Impella 2.5 heart pump. Jersey Shore is the first and only regional hospital to include the World's Smallest Heart Pump in their portfolio of treatment options to assist critically ill heart patients.

19 Oct 2011

King's researchers create traditional Chinese medicine database

A comprehensive database developed by King's College London researchers that features the chemical components found in traditional Chinese medicines has been released to market this month, allowing researchers to explore age-old remedies in the search for tomorrow's new drugs.

19 Oct 2011

Medicare reimbursements high for digital mammography — though test may be no more effective than less expensive ones

High-tech, digital mammography may not be any better at detecting breast cancer in women over 65 than older film-based systems, but Medicare is spending millions of taxpayer dollars reimbursing the procedure at a far higher rate. A new study comparing digital mammography with less expensive film mammography found that the two types of breast cancer screens are equally effective at detecting cancers in most women. ... The study was performed by the National Cancer Institute-funded Breast Cancer Surveillance Consortium.

19 Oct 2011

Christie introduces hand-held version of VeinViewer

Christie Medical Holdings, Inc. today announced the market launch of the company's newest product, VeinViewer Flex. With the addition of this fifth-generation VeinViewer, following the recent launch of VeinViewer VisionXTND, Christie now provides a full portfolio of three product tiers that addresses the needs of every major health care market segment.

18 Oct 2011

FDA clears Spineology's Rampart line of Interbody fusion implants

Spineology Inc.,the innovator in anatomy-conserving spine surgery, announced today that it has received FDA clearance for, and is initiating launch of, the new Rampart™ line of Interbody fusion implants.

18 Oct 2011

Focusing on disease eradication rather than control 'can pay off'

"Work on malaria suggests that focusing on the science and technology required to eliminate a disease, rather than just control it, can pay off -- and that such approaches could be applied to other diseases," SciDev.Net Editor David Dickson writes in a SciDev.Net editorial.

18 Oct 2011

Mass spectrometry reveals precise spatial distribution of drug within tissue

When a new drug is developed, the manufacturer must be able to show that it reaches its intended goal in the body's tissue, and only that goal. Such studies could be made easier with a new method now established at Lund University in Sweden.

18 Oct 2011

UTA technology could reduce time and cost to finding a cure for Alzheimer's

Technology developed by researchers at The University of Texas at Austin could significantly reduce the time and cost to finding a cure for Alzheimer's disease and help answer one of the greatest biological questions: why do we age?

18 Oct 2011

BIOTRONIK introduces line extension to its popular 4 F compatible, self-expanding stent system

BIOTRONIK AG, a leading manufacturer of vascular interventional devices, announced the introduction of a line extension to its popular 4 F compatible, self-expanding stent system dedicated for the treatment of long disease segments in the superficial femoral artery (SFA) and infrapopliteal arteries.

18 Oct 2011

First study ever to instrument child football helmets

Virginia Tech released today results from the first study ever to instrument child football helmets. Youth football helmets are currently designed to the same standards as adult helmets, even though little is known about how child football players impact their heads.

18 Oct 2011

FDA clears Cook Medical's Evolution Duodenal Controlled-Release Stent

Cook Medical announced today that its Evolution Duodenal Controlled-Release Stent was recently granted 510(k) clearance by the Food & Drug Administration.

18 Oct 2011

New DNA-based prenatal blood test can identify pregnancy with Down syndrome

A new DNA-based prenatal blood test that can strikingly reduce the number of risky diagnostic procedures needed to identify a pregnancy with Down syndrome is ready to be introduced into clinical practice.

18 Oct 2011

St. Jude Medical commences use of renal denervation catheter and generator system

St. Jude Medical, Inc., a global medical device company, today announced the first use of the company's renal denervation catheter and generator system, as part of a feasibility study of the new technology. The technology was developed as a treatment for resistant hypertension (high blood pressure that is not well controlled by drug therapy).

18 Oct 2011

Genomatix is among the 41 partners of BLUEPRINT epigenome consortium

Genomatix is among the 41 partners of the BLUEPRINT epigenome consortium funded by the European Commission as a high impact project within its seventh framework program.

18 Oct 2011

Micro-electrical stimulators for spinal cord injuries

A new wireless device to help victims of spinal cord injury is receiving attention in the research community. Mesut Sahin, PhD, associate professor, in the department of biomedical engineering at NJIT, recently has published and presented news of his findings to develop micro-electrical stimulators for individuals with spinal cord injuries.

18 Oct 2011

vRad announces premier radiology partnership with ICON

Virtual Radiologic (vRad), a technology-enabled national radiology practice, has announced a premier radiology partnership with ICON Medical Imaging (ICON), the medical imaging division of ICON plc.

18 Oct 2011

Nephron Dx to develop more accurate diagnostic kit for early detection of diabetic CKD

A new spin-off company from the National University of Singapore (NUS), called Nephron Dx, has recently been set up to develop a more accurate diagnostic kit for the earlier detection of diabetic chronic kidney disease. Nephron Dx aims to enter the multi-billion dollar kidney disease diagnostic market by 2013.

18 Oct 2011

FDA clears BioHelix IsoAmp HSV molecular diagnostic assay

BioHelix Corporation has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the company's first molecular diagnostic assay, the IsoAmp HSV Assay. The diagnostic test is intended for the detection of Herpes Simplex Virus (HSV1 & HSV2) in genital and oral lesion specimens from symptomatic patients.

18 Oct 2011

NEP successfully inserts specific doses of anti-cancer gene into leukemia cells

For the first time, researchers have found a way to inject a precise dose of a gene therapy agent directly into a single living cell without a needle.

18 Oct 2011

Scientists discover a way to accurately map typhoid outbreaks in the city

In the mid-nineteenth century, John Snow mapped cases of cholera in Soho, London, and traced the source of the outbreak to a contaminated water pump. Now, in a twenty-first century equivalent, scientists funded by the Wellcome Trust working in Kathmandu, Nepal, have combined the latest in gene sequencing technology and global positioning system (GPS) case localisation to map the spread of typhoid and trace its source.

18 Oct 2011